These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1063 related articles for article (PubMed ID: 20152549)

  • 1. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia.
    Cooper D; Moisan J; Gaudet M; Abdous B; Grégoire JP
    Can J Psychiatry; 2005 Dec; 50(14):901-8. PubMed ID: 16494259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
    Hassan M; Madhavan SS; Kalsekar ID; Makela EH; Rajagopalan K; Islam S; Kavookjian J; Miller LA
    Ann Pharmacother; 2007 Nov; 41(11):1812-8. PubMed ID: 17925501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
    Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions.
    Wheeler A
    N Z Med J; 2006 Jul; 119(1237):U2055. PubMed ID: 16862201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
    Ward A; Ishak K; Proskorovsky I; Caro J
    Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
    Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
    J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate.
    Cramer JA; Sernyak M
    Clin Ther; 2004 Jun; 26(6):905-14. PubMed ID: 15262461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
    Gianfrancesco F; Pesa J; Wang RH
    J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
    Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):83-94. PubMed ID: 22306198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
    Gianfrancesco FD; Rajagopalan K; Sajatovic M; Wang RH
    J Clin Psychiatry; 2006 Feb; 67(2):222-32. PubMed ID: 16566617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia.
    Kreyenbuhl J; Slade EP; Medoff DR; Brown CH; Ehrenreich B; Afful J; Dixon LB
    Schizophr Res; 2011 Sep; 131(1-3):127-32. PubMed ID: 21576008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
    Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
    N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
    McEvoy JP; Lieberman JA; Stroup TS; Davis SM; Meltzer HY; Rosenheck RA; Swartz MS; Perkins DO; Keefe RS; Davis CE; Severe J; Hsiao JK;
    Am J Psychiatry; 2006 Apr; 163(4):600-10. PubMed ID: 16585434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
    Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
    Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.